Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitomi Takada

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Viral Hepatitis|April 12, 2019
Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antiviralsNobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 8, 2015
Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapyJun Itakura, Masayuki Kurosaki, Hitomi Takada, et al.
Hepatology Communications|September 24, 2021
Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment EfficacyMasaru Muraoka, Shinya Maekawa, Ryo Katoh, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 7, 2015
Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patientsNobuharu Tamaki, Masayuki Kurosaki, Atsushi Kuno, et al.
Hepatology Communications|March 31, 2022
Analysis of direct-acting antiviral-resistant hepatitis C virus haplotype diversity by single-molecule and long-read sequencingKozue Yamauchi, Mitsuaki Sato, Leona Osawa, et al.
Plos One|August 16, 2016
Correction: Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular CarcinomaYutaka Yasui, Tokiya Abe, Masayuki Kurosaki, et al.
Plos One|April 30, 2016
Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular CarcinomaYutaka Yasui, Tokiya Abe, Masayuki Kurosaki, et al.
Cancers|August 30, 2019
Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular CarcinomaHitomi Takada, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Nutrients|May 13, 2026
Serum Zinc Threshold and the Prognostic Impact of Zinc Supplementation in Liver CirrhosisYuki Tanaka, Nobuharu Tamaki, Hiroyuki Nakanishi, et al.
International Journal of Molecular Sciences|April 3, 2021
MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA SequencingNatsuhiko Kuratomi, Shinichi Takano, Mitsuharu Fukasawa, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Viral Hepatitis|April 12, 2019
Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antiviralsNobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 8, 2015
Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapyJun Itakura, Masayuki Kurosaki, Hitomi Takada, et al.
Hepatology Communications|September 24, 2021
Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment EfficacyMasaru Muraoka, Shinya Maekawa, Ryo Katoh, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 7, 2015
Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patientsNobuharu Tamaki, Masayuki Kurosaki, Atsushi Kuno, et al.
Hepatology Communications|March 31, 2022
Analysis of direct-acting antiviral-resistant hepatitis C virus haplotype diversity by single-molecule and long-read sequencingKozue Yamauchi, Mitsuaki Sato, Leona Osawa, et al.
Plos One|August 16, 2016
Correction: Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular CarcinomaYutaka Yasui, Tokiya Abe, Masayuki Kurosaki, et al.
Plos One|April 30, 2016
Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular CarcinomaYutaka Yasui, Tokiya Abe, Masayuki Kurosaki, et al.
Cancers|August 30, 2019
Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular CarcinomaHitomi Takada, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Nutrients|May 13, 2026
Serum Zinc Threshold and the Prognostic Impact of Zinc Supplementation in Liver CirrhosisYuki Tanaka, Nobuharu Tamaki, Hiroyuki Nakanishi, et al.
International Journal of Molecular Sciences|April 3, 2021
MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA SequencingNatsuhiko Kuratomi, Shinichi Takano, Mitsuharu Fukasawa, et al.
Pageof 8